R. Gaynes and J. Edwards, National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by gram-negative bacilli, Clin. Infect. Dis, vol.41, pp.848-854, 2005.

M. A. Matthay, L. B. Ware, and G. A. Zimmerman, The acute respiratory distress syndrome, Journal of Clinical Investigation, vol.122, issue.8, pp.2731-2740, 2012.
DOI : 10.1172/JCI60331

L. Van-maele, Activation of Type 3 Innate Lymphoid Cells and Interleukin 22 Secretion in the Lungs During Streptococcus pneumoniae Infection, The Journal of Infectious Diseases, vol.37, issue.3, pp.493-503, 2014.
DOI : 10.1016/j.immuni.2012.08.024

URL : https://hal.archives-ouvertes.fr/inserm-01182903

X. Xu, Conventional NK Cells Can Produce IL-22 and Promote Host Defense in Klebsiella pneumoniae Pneumonia, The Journal of Immunology, vol.192, issue.4, pp.1778-1786, 2014.
DOI : 10.4049/jimmunol.1300039

URL : http://www.jimmunol.org/content/jimmunol/192/4/1778.full.pdf

M. Hansson, E. Silverpil, A. Lindén, and P. Glader, Interleukin-22 produced by alveolar macrophages during activation of the innate immune response, Inflammation Research, vol.169, issue.10, pp.561-569, 2013.
DOI : 10.4049/jimmunol.169.10.5673

C. L. Zindl, IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis, Proceedings of the National Academy of Sciences, vol.445, issue.7128, pp.12768-12773, 2013.
DOI : 10.1038/nature05505

J. A. Dudakov, A. M. Hanash, and M. R. Van-den-brink, Interleukin-22: Immunobiology and Pathology, Annual Review of Immunology, vol.33, issue.1, pp.747-785, 2015.
DOI : 10.1146/annurev-immunol-032414-112123

URL : http://europepmc.org/articles/pmc4407497?pdf=render

K. Wolk, IL-22 Increases the Innate Immunity of Tissues, Immunity, vol.21, issue.2, pp.241-254, 2004.
DOI : 10.1016/j.immuni.2004.07.007

R. Sabat, W. Ouyang, and K. Wolk, Therapeutic opportunities of the IL-22???IL-22R1 system, Nature Reviews Drug Discovery, vol.33, issue.1, pp.21-38, 2013.
DOI : 10.1016/j.it.2012.02.007

S. J. Aujla, IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia, Nature Medicine, vol.99, issue.3, pp.275-281, 2008.
DOI : 10.1152/ajplung.00169.2002

URL : http://europepmc.org/articles/pmc2901867?pdf=render

Y. Zheng, Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens, Nature Medicine, vol.151, issue.3, pp.282-289, 2008.
DOI : 10.4049/jimmunol.172.5.2827

M. A. Gessner, ABSTRACT, Infection and Immunity, vol.80, issue.1, pp.410-417, 2012.
DOI : 10.1128/IAI.05939-11

J. Mear, ABSTRACT, Infection and Immunity, vol.82, issue.1, pp.306-315, 2014.
DOI : 10.1128/IAI.01085-13

J. A. Dudakov, Interleukin-22 Drives Endogenous Thymic Regeneration in Mice, Science, vol.329, issue.1-2, pp.91-95, 2012.
DOI : 10.1016/j.jim.2007.09.010

P. L. Simonian, ???? T cells protect against lung fibrosis via IL-22, The Journal of Experimental Medicine, vol.154, issue.10, pp.2239-2253, 2010.
DOI : 10.1038/nm1720

URL : http://jem.rupress.org/content/jem/207/10/2239.full.pdf

S. Radaeva, R. Sun, H. Pan, F. Hong, and B. Gao, Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation, Hepatology, vol.1, issue.5, pp.1332-1342, 2004.
DOI : 10.4049/jimmunol.171.7.3863

G. F. Sonnenberg, L. A. Fouser, and D. Artis, Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22, Nature Immunology, vol.148, issue.5, pp.383-390, 2011.
DOI : 10.1164/ajrccm/148.6_Pt_1.1523

M. Muñoz, ???induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17, The Journal of Experimental Medicine, vol.118, issue.13, pp.3047-3059, 2009.
DOI : 10.1038/nm1720

G. K. Perera, Integrative Biology Approach Identifies Cytokine Targeting Strategies for Psoriasis, Science Translational Medicine, vol.103, issue.46, pp.223-245, 2014.
DOI : 10.1073/pnas.0608396103

G. F. Sonnenberg, Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A, The Journal of Experimental Medicine, vol.118, issue.6, pp.1293-1305, 2010.
DOI : 10.1038/nm1720

L. Dumoutier, D. Lejeune, D. Colau, and J. Renauld, Cloning and Characterization of IL-22 Binding Protein, a Natural Antagonist of IL-10-Related T Cell-Derived Inducible Factor/IL-22, The Journal of Immunology, vol.166, issue.12, pp.7090-7095, 2001.
DOI : 10.4049/jimmunol.166.12.7090

J. C. Martin, IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis, Mucosal Immunology, vol.118, issue.2, pp.539-549, 2016.
DOI : 10.1126/science.1172447

J. C. Martin, Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid, Mucosal Immunology, vol.172, issue.1, pp.101-113, 2014.
DOI : 10.4049/jimmunol.172.12.7485

H. A. Whittington, L. Armstrong, K. M. Uppington, and A. B. Millar, Interleukin-22, American Journal of Respiratory Cell and Molecular Biology, vol.31, issue.2, pp.220-226, 2004.
DOI : 10.1016/0140-6736(93)90416-E

B. Lorraine and J. A. Ware, Alveolar Epithelial Fluid Transport Capacity in Reperfusion Lung Injury after Lung Transplantation, pp.1-9, 1999.

A. Broquet, A. Roquilly, C. Jacqueline, and G. Potel, Depletion of Natural Killer Cells Increases Mice Susceptibility in a Pseudomonas aeruginosa Pneumonia Model*, Critical Care Medicine, vol.42, issue.6, pp.441-50, 2014.
DOI : 10.1097/CCM.0000000000000311

M. M. Lemaire, A. Vanhaudenarde, Y. Nizet, L. Dumoutier, and J. Renauld, Induction of autoantibodies against mouse soluble proteins after immunization with living cells presenting the autoantigen at the cell surface in fusion with a human type 2 transmembrane protein, Journal of Immunological Methods, vol.367, issue.1-2, pp.56-62, 2011.
DOI : 10.1016/j.jim.2011.02.001

S. Vaishnava, The Antibacterial Lectin RegIII?? Promotes the Spatial Segregation of Microbiota and Host in the Intestine, Science, vol.119, issue.1, pp.255-258, 2011.
DOI : 10.1016/S1095-6433(97)00434-0

J. P. Mcaleer and J. K. Kolls, Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense, Immunological Reviews, vol.37, issue.1, pp.129-144, 2014.
DOI : 10.1016/j.immuni.2012.05.020

R. D. Pechous, With Friends Like These: The Complex Role of Neutrophils in the Progression of Severe Pneumonia, Frontiers in Cellular and Infection Microbiology, vol.24, p.119, 2017.
DOI : 10.1016/j.pupt.2011.08.001

A. Y. Koh, G. P. Priebe, C. Ray, N. Van-rooijen, and G. B. Pier, Inescapable Need for Neutrophils as Mediators of Cellular Innate Immunity to Acute Pseudomonas aeruginosa Pneumonia, Infection and Immunity, vol.77, issue.12, pp.5300-5310, 2009.
DOI : 10.1128/IAI.00501-09

A. E. Williams and R. C. Chambers, The mercurial nature of neutrophils: still an enigma in ARDS?, American Journal of Physiology-Lung Cellular and Molecular Physiology, vol.76, issue.3, pp.217-247, 2014.
DOI : 10.1172/JCI119475

A. Guillon, Neutrophil proteases alter the interleukin-22-receptor-dependent lung antimicrobial defence, European Respiratory Journal, vol.46, issue.3, pp.771-782, 2015.
DOI : 10.1183/09031936.00215114

URL : http://erj.ersjournals.com/content/erj/46/3/771.full.pdf

G. Trevejo-nunez, W. Elsegeiny, P. Conboy, K. Chen, and J. K. Kolls, Critical Role of IL-22/IL22-RA1 Signaling in Pneumococcal Pneumonia, The Journal of Immunology, vol.59, issue.10, pp.10-40491600528, 2016.
DOI : 10.1099/jmm.0.017798-0

E. J. Miller, Elevated Levels of NAP-1/Interleukin-8 Are Present in the Airspaces of Patients with the Adult Respiratory Distress Syndrome and Are Associated with Increased Mortality, American Review of Respiratory Disease, vol.125, issue.2, pp.427-432, 1992.
DOI : 10.1073/pnas.84.24.9233

E. J. Miller, A. B. Cohen, and M. A. Matthay, Increased interleukin-8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome from sepsis, Critical Care Medicine, vol.24, issue.9, pp.1448-1454, 1996.
DOI : 10.1097/00003246-199609000-00004

S. Hoegl, Protective Properties of Inhaled IL-22 in a Model of Ventilator-Induced Lung Injury, American Journal of Respiratory Cell and Molecular Biology, vol.44, issue.3, pp.369-376, 2011.
DOI : 10.1097/01.CCM.0000178179.48050.BC

S. V. Kotenko, Identification, Cloning, and Characterization of a Novel Soluble Receptor That Binds IL-22 and Neutralizes Its Activity, The Journal of Immunology, vol.166, issue.12, pp.7096-7103, 2001.
DOI : 10.4049/jimmunol.166.12.7096

W. Xu, A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist, Proceedings of the National Academy of Sciences, vol.147, issue.1, pp.9511-9516, 2001.
DOI : 10.1016/0022-2836(81)90087-5

URL : http://www.pnas.org/content/98/17/9511.full.pdf

G. F. Weber, Inhibition of Interleukin-22 Attenuates Bacterial Load and Organ Failure during Acute Polymicrobial Sepsis, Infection and Immunity, vol.75, issue.4, pp.1690-1697, 2007.
DOI : 10.1128/IAI.01564-06

J. C. Martin, Limited Presence of IL-22 Binding Protein, a Natural IL-22 Inhibitor, Strengthens Psoriatic Skin Inflammation, The Journal of Immunology, vol.6, issue.9, pp.3671-3678, 2017.
DOI : 10.1038/sj.gene.6364104